GP
BSX icon

Guardian Partners’s Boston Scientific BSX Stock Holding History

Guardian Partners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
+295
New +$16K ﹤0.01% 335

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Guardian Partners's BSX Position: Q2 2026 in Review

Guardian Partners opened a new position in Boston Scientific (BSX) in Q2 2026: 295 shares worth $12.6K. The stake represents ﹤0.01% of the portfolio and ranks #335 among its holdings.

479 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Guardian Partners held 295 shares of Boston Scientific worth $12.6K as of Q2 2026.
  • Boston Scientific was a new Guardian Partners position in Q2 2026.
  • Boston Scientific made up ﹤0.01% of Guardian Partners's portfolio in Q2 2026, its #335 holding.
  • 479 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.